Saint Louis, Missouri 63110


Purpose:

The purpose of this study is to determine whether postpartum administration of furosemide to women with antepartum hypertensive disorders (gestational hypertension, preeclampsia) or elevated blood pressure in the first 24 hours following delivery reduces severe postpartum hypertension.


Criteria:

Inclusion Criteria: Women > 18 years of age or emancipated minors Women undergoing vaginal or cesarean delivery at > 23 weeks gestation with: - Antepartum diagnosis of gestational hypertension - Antepartum diagnosis of preeclampsia - Antepartum diagnosis of preeclampsia with severe features - Mild hypertension (<150/100) in first 24 hours following delivery Exclusion Criteria: - Chronic hypertension - Allergy to furosemide - Pre-existing hypokalemia (serum K < 3.0 meq/L) - Chronic kidney disease - Serum Cr > 1.1 - Inability to obtain informed consent - Pre-existing diuretic use - Oliguria


NCT ID:

NCT02450773


Primary Contact:

Principal Investigator
Methodius G. Tuuli, MD, MPH
Washington University School of Medicine

Shannon A Martin, RN
Phone: 314-362-8523
Email: martins@wudosis.wustl.edu


Backup Contact:

N/A


Location Contact:

Saint Louis, Missouri 63110
United States

Shannon Martin

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 21, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.